Advertisement

Conduits and Filters for Extracorporeal Circulation

  • Kathy K. Spitzer
  • Charles T. Walker

Abstract

This chapter discusses the conduits used for conducting blood through the extracorporeal circuit. These conduits must be large enough to offer a low resistance to flow, yet small enough to minimize priming volume. To avoid trauma to formed blood elements, they should have smooth, nonwettable inside surfaces. Filters are incorporated into the circuit to remove air, debris, and aggregated blood elements. Each of these three circuitry components — tubing, cannulas, and filters — is considered separately.

Keywords

Cardiopulmonary Bypass Extracorporeal Circulation Extracorporeal Circuit Roller Pump Venous Cannula 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Direct communication with Lawrence E. Czyz, Vice President and General Manager, Plastron. 19555 E. Arenth Ave., City of Industry, CA 91748.Google Scholar
  2. 2.
    Hoenich NA, Thompson J, Varini E, et al. Particle Spallation Plasticizer (DEHP) release from extracorporeal cir-cuit tubing materials. Int J A rtif Organs 1990; 13: 55–62Google Scholar
  3. 3.
    Hodge R, Leverett B, Akers WW. Abrasion of Pump Sets in Roller Pumps. Report No. 6503, Bio-Medical Engineering Laboratory, Rice University, Houston, TX, 1965.Google Scholar
  4. 4.
    Boretos JW. Silicone Polymers in Medicine and Surgery. New York: Plenum Press; 1975: 87–98.Google Scholar
  5. 5.
    Kurusz M, Christman E, Williams E, et al. Roller-pump induced tubing wear: another argument in favor of arterial line filtration. J Extracorp Tech 1980; 12: 49–59.Google Scholar
  6. 6.
    Bretz G, Schermeyer T, Donnelly T. Long term tubing fatigue characteristics. J Extracorp Tech 1979; 11: 151–156.Google Scholar
  7. 7.
    Pfaender LM, Riley JB, Whitehead JB, et al. An in vitro comparison of the effects of temperature on the stroke volume and occlusion setting of various tubing types in a roller pump. J Extracorp Tech 1979; 11: 78–88.Google Scholar
  8. 8.
    Wesolowski SA, Martinez A, McMahon JD. Use of artificial materials in surgery. Curr Prob Surg 1966; 12: 1–86.CrossRefGoogle Scholar
  9. 9.
    Nilsson L, Nilsson U, Venge P, et al. Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: a randomized comparison of bubble and membrane oxygenators. Scand J Thorac Cardiovasc Surg 1990; 24: 53–58.PubMedGoogle Scholar
  10. 10.
    van Oeveren W, Wildevuur CR. Blood compatibility of cardiopulmonary bypass circuits. Perfusion 1987; 2: 237–244.CrossRefGoogle Scholar
  11. 11.
    Gurjar Y, Bowman JM. Prevention of platelet adhesion to extracorporeal surfaces. J Extracorp Tech 1984; 16: 104–107.Google Scholar
  12. 12.
    Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Devices Artif Organs 1983; 2: 161–173.Google Scholar
  13. 13.
    Pasche B, Kodama K, Larm O, et al. Thrombin inactivation of surfaces with covalently bonded heparin. Thromb Res 1986; 44: 739–748.PubMedCrossRefGoogle Scholar
  14. 14.
    Videm V, Mollnes T, Garred P, et al. Biocompatibility of extracorporeal circulation. J Thorac Cardiovasc Surg 1991; 101: 654–660.PubMedGoogle Scholar
  15. 15.
    Barbucci R, Magnani A, Albanese A, et al. Heparinized Polyurethane surface through ionic bonding of heparin. Int J Artif Organs 1991; 14: 499–507.PubMedGoogle Scholar
  16. 16.
    Shumway R, Lowe N, Wirth L, et al. Functional characteristic determination of an immobilized bioactive heparin surface, a direct biological assay. Presented at the American Academy of Cardiac Perfusionists; September 1990; Chicago.Google Scholar
  17. 17.
    Medtronic/Carmeda Bioactive Surface, An Overview. Anaheim, CA: Medtronic, Compendium of Scientific Information; 1990.Google Scholar
  18. 18.
    Nilsson L, Storm K, Thelin S, et al. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif Organs 1990; 14: 46–48.PubMedCrossRefGoogle Scholar
  19. 19.
    Thelin S, Bylock A, Bagge L, et al. Heparin coated cardiopulmonary bypass sets during surgery-clinical study. Presented at the American Society of Extracorporeal Technologists Annual Meeting; April 1990; Dallas.Google Scholar
  20. 20.
    Videm V, Svennevig J, Fosse E, et al. Complement activation with a heparin coated cardiopulmonary bypass device. Presented at American Heart Association, Dallas, November, 1990.Google Scholar
  21. 21.
    Bindslev L, Böhm C, Jolin A, et al. Extracorporeal carbon dioxide removal performed with surface-heparinized equipment in patients with ARDS. Acta Anaesth Scand Supple-mentum. 1991; 95: 125–130.CrossRefGoogle Scholar
  22. 22.
    Boonstra PW, Gu YJ, Akkerman C, et al. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 107: 289–292.PubMedGoogle Scholar
  23. 23.
    Swank RL, Port GA. Disappearance of microemboli transfused into patients during cardiopulmonary bypass. Transfusion 1963; 3: 192–197.PubMedCrossRefGoogle Scholar
  24. 24.
    Jenevein EP, Weiss DL. Platelet microemboli associated with massive blood transfusion. Am J Pathol 1964; 45: 313–325.PubMedGoogle Scholar
  25. 25.
    Patterson RH, Kessler J. Microemboli during cardiopulmonary bypass detected by ultrasound. Surgery 1969; 129: 505–510.Google Scholar
  26. 26.
    Berman L, Marin F. Micropore filtration during cardiopulmonary bypass. In: Taylor M, ed., Cardiopulmonary Bypass: principles and management. Cambridge: University Press, 1986: 355–374.Google Scholar
  27. 27.
    Bailey R, Lumley J. Some observations on blood microfilt-ers. Ann R Coll Surg 1975; 43: 578–581.Google Scholar
  28. 28.
    Hill AG, Groom RG, Kurusz M, et al. Arterial filtration: heparin bonded or unbonded: a comparison. ProcAm Acad Cardiovasc Perf 1985; 6: 132–139.Google Scholar
  29. 29.
    Palanzo DA, Kurusz M, Butler BD. Surface tension effects of heparin coating on arterial line filters. Perfusion 1990; 5: 277–284.PubMedCrossRefGoogle Scholar
  30. 30.
    Rand PW, Lancombe E, Hunt HE, et al. Viscosity of normal human blood under normo-thermic and hypothermic conditions. JAppl Physiol 1964; 19: 119–122.Google Scholar
  31. 31.
    Pfaender LM, Riley JB. Viscosity-induced resistance changes during bypass with hemodilution and hypothermia. Presented at the American Society of Extracorporeal Technology, Boca Raton, FL, 1984.Google Scholar
  32. 32.
    Kemma GD, Doeherty JP. Why filter the cardiopulmonary circuit pre-bypass? J Extracorp Tech 1979; 11: 121–124.Google Scholar
  33. 33.
    Ream AK, Fogdall RR. Acute Cardiovascular Management. Philadelphia: JB Lippincott; 1982: 444.Google Scholar
  34. 34.
    Reed CC, Stafford TB. Cardiopulmonary Bypass. Houston: Texas Medical Press; 1985: 344.Google Scholar
  35. 35.
    Lin ELC, Goldstein R, Syvannen M. Bacteria, PI asm ids, and Phages: An Introduction to Molecular Biology. Cambridge, Mass: Harvard University Press; 1984: 25.Google Scholar
  36. 36.
    Jenkins BS. The clinical manifestation of endotoxin shock arising from high level contamination. In: Microbiological Hazards of Infusion Therapy. Proceedings of an international symposium held at the University of Sussex, England, March 1976. Littleton, Mass: Publishing Sciences Group; 1976: 93–97.Google Scholar
  37. 37.
    Lowe GD. Filtration in IV therapy—Review of the clinical and technical aspects of intravenous fluid and blood filtration in four parts —IV: Blood filters. Br J Intraven Ther 1981; 2: 24–38.Google Scholar
  38. 38.
    Mortensen JD, Smith SM, Hill G. Bacterial contamination of oxygen used in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1961; 41: 675–679.PubMedGoogle Scholar
  39. 39.
    Mortenson JD, Hurd G, Hill G. Bacterial contamination of oxygen used clinically—importance and one method of control. Dis Chest 1962; 42: 567–572.CrossRefGoogle Scholar
  40. 40.
    Mortenson JD, Hill G. Clinical and bacteriologic evaluation of a new filter designed specifically for bacteriologic decontamination of oxygen used clinically. Dis Chest 1964; 45: 508–514.CrossRefGoogle Scholar
  41. 41.
    Kurusz M. Perfusion accidents in the 1970s and 1980s: comparison of two surveys. Presented at the Second World Congress on Open Heart Technology; October 7–11, 1986; Tampa.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1995

Authors and Affiliations

  • Kathy K. Spitzer
  • Charles T. Walker

There are no affiliations available

Personalised recommendations